Avidity Biosciences, Inc. ($RNAM)
Filing Information
| Accession Number | 0001193125-26-082275 |
|---|---|
| Form Type | 4 |
| Filing Date | Feb 27, 2026 |
| Document | View SEC Filing |
Transactions
8
Total Shares
2,650,876
Total Value
$0.00
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | Feb 27, 2026 | Sale to Issuer | 474,861 | โ | โ | 0 | Direct | โ | View Details | |
Director | Stock Option (Right to Buy) | Derivative | Feb 27, 2026 | Sale to Issuer | 386,015 | โ | โ | 0 | Direct | โ | View Details | |
Director | Stock Option (Right to Buy) | Derivative | Feb 27, 2026 | Sale to Issuer | 300,000 | โ | โ | 0 | Direct | โ | View Details | |
Director | Stock Option (Right to Buy) | Derivative | Feb 27, 2026 | Sale to Issuer | 425,000 | โ | โ | 0 | Direct | โ | View Details | |
Director | Stock Option (Right to Buy) | Derivative | Feb 27, 2026 | Sale to Issuer | 400,000 | โ | โ | 0 | Direct | โ | View Details | |
Director | Stock Option (Right to Buy) | Derivative | Feb 27, 2026 | Sale to Issuer | 200,000 | โ | โ | 0 | Direct | โ | View Details | |
Director | Stock Option (Right to Buy) | Derivative | Feb 27, 2026 | Sale to Issuer | 300,000 | โ | โ | 0 | Direct | โ | View Details | |
Director | Stock Option (Right to Buy) | Derivative | Feb 27, 2026 | Sale to Issuer | 165,000 | โ | โ | 0 | Direct | โ | View Details |